Schedule 13G ownership disclosure

CATALYST BIOSCIENCES INC

Security class unavailable · CUSIP: 14888D208

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
355,373
Percent of class
7.5500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001037389-18-000011
Form type
SC 13G
Filer
GYRE THERAPEUTICS, INC.
CIK
CIK 1124105
Filed
Feb 14, 2018
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub